JUXTAPID
Swiss trademark · 660437 · Word mark · In force
Register entry
- Registration number
- 660437
- Application number
- 54406/2014
- Status
- In force
- Type
- Word mark
- Filed
- Apr 10, 2014
- Registered
- Jun 23, 2014
- Published
- Jun 23, 2014
- Protected until
- Apr 10, 2034
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Arzneimittel zur Behandlung von kardiovaskulären Störungen, insbesondere Hyperlipidämie.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 10, 2024
Renewed
Published in Swissreg on 10.04.2024
- Sep 26, 2022
Agent removed
- Representative
- BKS Rechtsanwälte AG, Thunstrasse 63, Postfach 371, 3000 Bern 6 (removed)
Published in Swissreg on 26.09.2022
- Sep 26, 2022
Transferred
- Owner
- Aegerion Pharmaceuticals, Inc., 101 Main Street, STE 1850, 02142 Cambridge, MA, USA → Amryt Pharmaceuticals, Inc., 160 Federal Street, 21st Floor, Boston, MA 02110, USA
- Representative
- Troller Hitz Troller, Rechtsanwälte, Münstergasse 38, 3011 Bern
Published in Swissreg on 26.09.2022
- Mar 4, 2021
Agent’s address changed
- Representative
- Beutler Künzi Stutz AG, Thunstrasse 63, Postfach 371, 3000 Bern 6 → BKS Rechtsanwälte AG, Thunstrasse 63, Postfach 371, 3000 Bern 6
Published in Swissreg on 04.03.2021
- Jan 9, 2018
Agent’s address changed
- Representative
- Beutler Künzi Stutz AG, Thunstrasse 63, 3000 Bern 6 → Beutler Künzi Stutz AG, Thunstrasse 63, Postfach 371, 3000 Bern 6
Published in Swissreg on 09.01.2018
- Jun 23, 2014
Registered
Published in Swissreg on 23.06.2014
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.